Investigation of the Possible Protective Effect of <i>N</i>-Acetylcysteine (NAC) against Irinotecan (CPT-11)-Induced Toxicity in Rats

Investigation of the Possible Protective Effect of <i>N</i>-Acetylcysteine (NAC) against Irinotecan (CPT-11)-Induced Toxicity in Rats

Irinotecan (CPT-11) is a chemotherapeutic agent involved in the treatment regimens for several malignancies such as colorectal cancer. <i>N</i>-acetylcysteine (NAC) is a strong antioxidant and anti-inflammatory agent used in the treatment of several diseases related to oxidative stress a...

Full description

Bibliographic Details
Main Authors:	Sevgi Gençosman, Deniz Ceylanlı, Ahmet Özer Şehirli, Kerem Teralı, Furkan Bölükbaşı, Şule Çetinel, Serkan Sayıner
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Antioxidants
Subjects:	cancer chemotherapy irinotecan <i>N</i>-acetylcysteine matrix metalloproteinase proinflammatory cytokines malondialdehyde
Online Access:	https://www.mdpi.com/2076-3921/11/11/2219

Similar Items

Protective effects of N-acetylcysteine against irinotecan – induced pulmonary toxicity in female albino rats
by: Hawrin Burhan Khudhur, et al.
Published: (2024-12-01)

<i>N</i>-Acetylcysteine (NAC): Impacts on Human Health
by: Micaely Cristina dos Santos Tenório, et al.
Published: (2021-06-01)

Effect of combination therapy with pramipexole and n-acetylcysteine on global cerebral ischemic reperfusion injury in rats
by: Ravi Chandra Sekhara Reddy Danduga, et al.
Published: (2018-06-01)

Evaluation of the Effectiveness of N-Acetylcysteine (NAC) and <i>N</i>-acetylcysteine-cyclodextrins Multi-Composite in <i>Pseudomonas aeruginosa</i> Biofilm Formation
by: Marta Guerini, et al.
Published: (2020-05-01)

Protective Effects of Alpha-Lipoic Acid against 5-Fluorouracil-Induced Gastrointestinal Mucositis in Rats
by: Deniz Ceylanlı, et al.
Published: (2022-09-01)

Direct Interaction between <i>N</i>-Acetylcysteine and Cytotoxic Electrophile—An Overlooked In Vitro Mechanism of Protection
by: Petr Mlejnek
Published: (2022-07-01)

The Effects of <i>N</i>-Acetylcysteine on the Rat Mesocorticolimbic Pathway: Role of mGluR5 Receptors and Interaction with Ethanol
by: Sandra Fernández-Rodríguez, et al.
Published: (2021-06-01)

BEVACIZUMAB IN COMBINATION WITH IRINOTECAN IN THE TREATMENT OF RECURRENT GLIOBLASTOMAS
by: D. R. Naskhletashvili, et al.
Published: (2015-04-01)

Repositioning <i>N</i>-Acetylcysteine (NAC): NAC-Loaded Electrospun Drug Delivery Scaffolding for Potential Neural Tissue Engineering Application
by: Gillian D. Mahumane, et al.
Published: (2020-09-01)

Irinotecan Induces Disease Remission in Xenograft Mouse Models of Pediatric <i>MLL</i>-Rearranged Acute Lymphoblastic Leukemia
by: Mark Kerstjens, et al.
Published: (2021-06-01)

Clinical outcomes of liposomal irinotecan in advanced pancreatic adenocarcinoma patients previously treated with conventional irinotecan-based chemotherapy: a real-world study
by: Amol Gupta, et al.
Published: (2023-08-01)

Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide
by: João Baetas, et al.
Published: (2019-02-01)

A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation
by: Jonathan L. Metts, et al.
Published: (2023-02-01)

Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity
by: Marwa S. Mahdy, et al.
Published: (2023-03-01)

GlyNAC (Glycine and <i>N</i>-Acetylcysteine) Supplementation Improves Impaired Mitochondrial Fuel Oxidation and Lowers Insulin Resistance in Patients with Type 2 Diabetes: Results of a Pilot Study
by: Rajagopal V. Sekhar
Published: (2022-01-01)

Rifaximin alleviates irinotecan-induced diarrhea in mice model
by: Chengyi Huang, et al.
Published: (2024-12-01)

Full-profile pharmacokinetics, anticancer activity and toxicity of an extended release trivalent PEGylated irinotecan prodrug
by: Shiwen Song, et al.
Published: (2023-08-01)

Systematic Review of Human and Animal Studies Examining the Efficacy and Safety of N-Acetylcysteine (NAC) and N-Acetylcysteine Amide (NACA) in Traumatic Brain Injury: Impact on Neurofunctional Outcome and Biomarkers of Oxidative Stress and Inflammation
by: Junaid Bhatti, et al.
Published: (2018-01-01)

Dissolution of Biofilm Secreted by Three Different Strains of <i>Pseudomonas aeruginosa</i> with Bromelain, <i>N</i>-Acetylcysteine, and Their Combinations
by: Carly J. Carter, et al.
Published: (2021-12-01)

A Retrospective Study of the Efficacy and Toxicity of Irinotecan in Combination with Nedaplatin versus Irinotecan in Combination with Cisplatin as Salvage Treatment in Refractory or Relapsed Small Cell Lung Cancer
by: Shufei YU, et al.
Published: (2013-09-01)

Subchronic <i>N</i>-acetylcysteine Treatment Decreases Brain Kynurenic Acid Levels and Improves Cognitive Performance in Mice
by: Tonali Blanco Ayala, et al.
Published: (2021-01-01)

A double‐blind randomized controlled trial of N‐acetylcysteine (NAC) for the treatment of acute exacerbation of chronic obstructive pulmonary disease
by: Wang Chung Kwok, et al.
Published: (2024-08-01)

The Alpha-Lipoic Acid Improves Survival and Prevents Irinotecan-Induced Inflammation and Intestinal Dysmotility in Mice
by: Daniely V. S. Costa, et al.
Published: (2020-11-01)

Long term survival in a patient with recurrent metastatic Ewing sarcoma treated with irinotecan and temozolomide
by: Hakan Gelincik, et al.
Published: (2016-12-01)

Design of Nanoplatforms for Targeted Delivery of Irinotecan
by: Ana-Maria Brezoiu, et al.
Published: (2022-03-01)

N-acetylcysteine as an adjunct treatment of schizophrenia
by: R. Mota Freitas, et al.
Published: (2021-04-01)

Medical and Dietary Uses of N-Acetylcysteine
by: Špela Šalamon, et al.
Published: (2019-04-01)

EXPERIENCE IN THE USE OF ACETYLCYSTEINE IN THE TREATMENT OF RESPIRATORY INFECTIONS IN YOUNG CHILDREN
by: I. V. Davydova, et al.
Published: (2012-04-01)

Amelioration of Cadmium-Induced Oxidative Damage in Wistar Rats by Vitamin C, Zinc and <i>N</i>-Acetylcysteine
by: Venkataramanaiah Poli, et al.
Published: (2022-01-01)

Effect of echinacoside as a palliative for irinotecan-induced intestinal mucositis
by: Хикару Оцуки, et al.
Published: (2023-12-01)

Advances in the Use of <i>N</i>-Acetylcysteine in Chronic Respiratory Diseases
by: Daniela Mokra, et al.
Published: (2023-09-01)

MRI Detection of Hepatic <i>N</i>-Acetylcysteine Uptake in Mice
by: Johnny Chen, et al.
Published: (2022-08-01)

Simvastatin enhances irinotecan-induced apoptosis in prostate cancer via inhibition of MCL-1
by: Mohammad A.Y. Alqudah, et al.
Published: (2018-02-01)

<i>N</i>-Acetylcysteine Inhibits Platelet Function through the Regeneration of the Non-Oxidative Form of Albumin
by: Sonia Eligini, et al.
Published: (2022-02-01)

N-acetylcysteine (NAC) Attenuating Apoptosis and Autophagy in RAW264.7 Cells in Response to Incubation with Mycolic Acid from Bovine Mycobacterium tuberculosis Complex
by: XUE LIN, et al.
Published: (2020-06-01)

Differential Neuroprotective Effects of <i>N</i>-Acetylcysteine against Dithianon Toxicity in Glutamatergic, Dopaminergic, and GABAergic Neurons: Assessment Using Zebrafish
by: Amit Banik, et al.
Published: (2023-10-01)

Effects of N-acetylcysteine on amphetamine-induced sensitization in mice
by: Ana P. Herrmann, et al.
Published: (2017-12-01)

N-Acetylcysteine, N-Acetylcysteine Amide, and Thioredoxin Mimetic Peptides Regenerate Mercaptoalbumin and Exhibit Antioxidant Activity
by: Sonia Eligini, et al.
Published: (2024-03-01)

Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line
by: Salah Mabrook Khallaf, et al.
Published: (2024-01-01)

Fungistatic Action of N-Acetylcysteine on <i>Candida albicans</i> Biofilms and Its Interaction with Antifungal Agents
by: Thaís Soares Bezerra Santos Nunes, et al.
Published: (2020-06-01)